FDA Proposes Rule Letting NAC Be Sold as a Supplement
The U.S. Food and Drug Administration issued a proposed rule on Monday, November 16, 2026, that would reverse the exclusion of N-acetyl-L-cysteine (NAC) from the definition of "dietary supplement." The rule would create a new regulation, "Dietary Ingredients Not Excluded from the Dietary Supplement Definition," with NAC as its first listed ingredient, and it will be open to public comment for 60 days.
NAC has been sold as a supplement for years under a policy of looking the other way. The FDA is now proposing to make the shelf legal, and it's building a new list to do it, one that other excluded ingredients could later join.
The Food and Drug Administration issued a proposed rule on Monday, November 16, 2026, that would let N-acetyl-L-cysteine, known as NAC, be lawfully marketed as a dietary supplement. NAC has been stuck in a legal oddity for years: it's sold widely in supplement aisles, while the FDA's stated position has been that it isn't a supplement at all. The proposal, if finalized, would reverse the exclusion of NAC from the definition of "dietary supplement" in federal law.
The mechanism is a new list. The proposed rule would create a regulation titled "Dietary Ingredients Not Excluded from the Dietary Supplement Definition," a place to name ingredients that the law would otherwise keep out of the supplement category. NAC would be the first ingredient on it. Products containing NAC could then be marketed as dietary supplements as long as they don't otherwise violate the Federal Food, Drug, and Cosmetic Act. The FDA is taking public comment on the proposal for 60 days.
The exclusion traces to a date: 1963. Federal law bars an ingredient from the supplement definition if it was approved as a drug, or authorized for substantial clinical investigation as one, before it was marketed as a supplement. The FDA says NAC was approved as a drug in 1963, decades before the modern supplement market, so the agency concluded in 2020, in warning letters aimed at hangover products, that NAC products were excluded from the definition. Supplement makers disputed the reading, sued and petitioned, and the bottles largely stayed on shelves while the argument ran.
What kept them there was enforcement discretion. In August 2022 the FDA issued final guidance saying it would exercise enforcement discretion for certain NAC products while it considered rulemaking, after an initial review that officials said hadn't revealed safety concerns. That truce is still the status quo in stores today: officially excluded, practically available. Monday's proposal is the rulemaking the agency floated four years ago, and it converts the truce into a legal category instead of a policy of not knocking.
The FDA is explicit about the direction of travel. The agency says the action, if finalized, counts as a deregulatory action under Executive Order 14192, "Unleashing Prosperity Through Deregulation," because it would allow NAC products to be lawfully marketed as supplements. STAT reported the proposal as a win for supplement proponents, noting that NAC is already widely sold over the counter and that the new classification amounts to the agency's first "not excluded" listing. A proposed rule isn't a final one: the comment window has to close, the agency has to answer what comes in, and only a final rule changes what's lawful on the shelf.
Until a final rule lands, the operative document in stores is still the FDA's final guidance on enforcement discretion for certain NAC products, the policy the agency issued alongside its 2022 rulemaking signal. Nothing about Monday's proposal changes a label, a listing or a shipment today. What it changes is the destination: instead of an ingredient sold under a standing decision not to enforce, NAC would sit in the supplement definition by name, and the "not excluded" regulation the FDA is creating would give the agency a standing way to settle the same drug-first dispute for other ingredients without starting from zero each time.
The conversation.
Loading comments…
A little more perspective.
Reading is free. Verified members can comment and reply for $2 a month.